Skip to main content

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Securities Class Action Lawsuit 02/25/2019

  • You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of December 28,  2022  by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 15, 2022 - The court granted preliminary approval of the settlement. May 5, 2022 - The parties entered into a stipulation and agreement of settlement. March 10, 2021 - The court granted in part and denied in part the defendants' motion to dismiss. June 9, 2020 - A motion to dismiss the amended complaint was filed. July 23, 2019 - An amended complaint was filed. February 25, ...



You must register (for free) or login to view the entire case.